Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA Genzyme, 28 Jan 2013 Accessed on 29 Jan 2013 from http://news.genzyme.com/press-release/genzymes-lemtrada-alemtuzumab-application-ms-accepted-review-fda. CommentRecommendBookmarkWatch